Sort by
Refine Your Search
-
Listed
-
Employer
- Delft University of Technology (TU Delft)
- Delft University of Technology (TU Delft); Delft
- University of Groningen
- Nature Careers
- Princess Máxima Center for Pediatric Oncology
- Princess Máxima Center for Pediatric Oncology; Utrecht
- Radboud University
- The Netherlands Cancer Institute
- The Netherlands Cancer Institute; Amsterdam
- Utrecht University
- Vrije Universiteit Amsterdam (VU)
- Wageningen University and Research Center
- 2 more »
- « less
-
Field
-
precise cancer removal. Utilizing Artificial Intelligence to Segment Echo Images of Tongue Cancer Intraoperatively to Facilitate Radical Resection Squamous cell carcinoma (SCC) of the tongue is a rare yet
-
surgeons to achieve more precise cancer removal. Utilizing Artificial Intelligence to Segment Echo Images of Tongue Cancer Intraoperatively to Facilitate Radical Resection Squamous cell carcinoma (SCC
-
Postdoctoral researcher for developing microfluidics for research on synthetic cells Job description In this project we will use the excellent microfabrication facilities of the Kavli Nanolab
-
to staff position within a Research Infrastructure? No Offer Description Postdoctoral researcher for developing microfluidics for research on synthetic cells Job description In this project we will use
-
Sciences and Biotechnology Institute (GBB) of the University of Groningen (The Netherlands), to investigate RNA structural ensemble dynamics in living cells. What The successful applicant will work on a
-
on the fundamental understanding and process optimization of an electrochemical cell system incorporating redox-flow electrodes and ion-selective membranes for Lithium purification. The goal is to selectively remove
-
multidisciplinary research team? Then we are looking for you! You will work on a 4-year project funded by the Dutch Research Council (NWO). This project is a collaboration between Erasmus University Medical Center
-
Organisation Job description Personalised medicine requires the correct selection of medications to appropriately address individual patient characteristics. In the case of non-small cell lung